Press Releases
Media Coverage 
Events  
 
 Scientific
 
Investor



   
Archives  
 

 

Q2 Newsletter

 

 


 


 

 

 

 

 

 

 

Use of this site constitutes agreement to our Terms and Conditions
and Privacy Policy. Site Design and Contents © 2008 CardioVascular BioTherapeutics, Inc. All Rights Reserved.

Some content on this site requires the free Adobe Reader.

 

9/9/2008
CVBT Announces First Site to Begin Patient Enrollment for Its Phase II Heart Trial


7/1/2008
Dutton Associates Announces Investment Opinion: CardioVascular BioTherapeutics Maintained At Neutral Rating By Dutton Associates


6/10/2008
CVBT Inks Third Clinical Development Agreement


5/22/2008
Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial